ACSBG2 and cancer: For downregulated lncRNAs, lnc-ACSBG2-1:1 and lnc-BOD1-1:7, -1:8, and -1:9 exhibit similar landscapes of pathway enrichment, where their low expression correlates with a high expression of genes in immune- and cancer-associated pathways, as represented by a negative enrichment score (Figure 3).